Clinical trial
Effects of Risperidone and Olanzapine on Patients With Schizophrenia…
NCT00179062 · Vanderbilt University, Other · Completed
Key facts
| NCT number | NCT00179062 |
|---|---|
| Title | Effects of Risperidone and Olanzapine on Patients With Schizophrenia, Schizoaffective Disorder, Major Depression or Bipolar Disorder |
| Official title | Effects of Risperidone and Olanzapine on Weight Gain, Physical Health, and Outcome in a Community Sample of Severity and Persistently Ill Patients |
| Lead sponsor | Vanderbilt University, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Schizophrenia, Schizoaffective Disorder, Depressive Disorder, Major, Bipolar Disorder |
| Intervention type | Drug |
| Interventions | olanzapine versus risperidone |
| Enrollment | 300 |
| Start date | Feb 1, 2000 |
| Primary completion | Jun 1, 2007 |
| Completion | Jun 1, 2007 |
| First posted | Sep 15, 2005 |
| Last update posted | Aug 26, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: